BioWorld Science

March 29, 2006

View Archived Issues

Pfizer presents novel renin inhibitors at 231st ACS National Meeting

Read More

Johnson & Johnson profile their new 11beta-HSD1 inhibitor

Read More

DIN-106935: a mixed ion channel inhibitor

Read More

AMG-131: novel modulator of PPARgamma for type 2 diabetes

Read More

Two activators of ferric sGC from sanofi-aventis

Read More

Antiproliferative efficacy of BMS-554417, an IGF-IR inhibitor

Read More

Korean approval for Quinvaxem pentavalent vaccine

Read More

Eisai seeks Japanese approval for Pariet in nonerosive GERD

Read More

Draximage realigns R&D priorities

Read More

Immtech begins pivotal study of pafuramidine maleate

Read More

Idera secures funding to advance pipeline

Read More

Elixir acquires rights to Glufast

Read More

Geron signs agreements with U. of Oxford for dendritic cell production

Read More

FemmePharma opens IND for topical cream to treat breast pain

Read More

Chinese data support efficacy of telbivudine in chronic hepatitis B

Read More

Akzo Nobel updates pipeline status

Read More

SD's nano-emulsion paclitaxel formulation demonstrates efficacy in preclinical tests

Read More

Japanese cooperative marketing of Abbott and Dainippon Sumitomo comes to end

Read More

Lundbeck begins phase I trials for Lu-AA34893 for depression

Read More

Rituximab well tolerated, beneficial in steroid-refractory graft-versus-host disease

Read More

Recent patents disclose novel antiinfective agents

Read More

New treatments for hepatitis C described in recent patent literature

Read More

Additional treatment and switching therapy effective in treating resistant depression

Read More

New analgesic agents imparted in recent patents

Read More

New study data on 7-valent vaccination for invasive pneumococcal disease presented

Read More

Exelixis advances XL-784 into phase II for diabetic nephropathy

Read More

Levemir made available in U.S.

Read More